Trial of Perioperative Endocrine Therapy - Individualising Care
Latest Information Update: 01 Jul 2024
At a glance
- Drugs Anastrozole (Primary) ; Letrozole (Primary) ; Antineoplastics
- Indications Early breast cancer; HER2 positive breast cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms POETIC
- 04 Jun 2024 Results assessing Molecular profiling after short-term preoperative endocrine therapy to identify oestrogen receptor positive (ER+)/HER2+ early breast tumours presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 01 Nov 2020 Results published in the Lancet Oncology.
- 19 Feb 2020 New source identified and integrated: (ClinicalTrials.gov: US National Institutes of Health: NCT02338310).